Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00434733 | Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects | PHASE3 | COMPLETED | 4,400 | — | — | Jan 1, 2007 | - | Apr 24, 2008 | 1 | Poland |
| Name | Type | Description |
|---|---|---|
| Pandemic influenza vaccine | BIOLOGICAL | - |
Inclusion Criteria: * Healthy Subjects 18 years of age who signed the informed consent Exclusion Criteria: * Receipt of another investigational agent within 4 weeks * Receipt of influenza vaccination for current season 2006/2007. * any acute disease or infection, history of neurological symptoms ...